Skip to content
★ Sign in to follow
OA

Ortoma A Stock: price and insider trades · Sweden

ISIN SE0013110046SE·

No insider purchase over the last 90 days. The latest, by Magnus Yngen, was filed 09 Sept 2021.

Ortoma A: what insiders have been doing

Ortoma A is a listed company. Its directors and officers file their transactions with Finansinspektionen. Nothing new has been filed by managers of Ortoma A in twelve months, the latest record being from 9 September 2021.

Our records for Ortoma A go back to 2019, with 5 purchases and no sales on the open market in total.

In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
5
Thresholds
n/a
Buy Volume
€89,158
5 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 9 September 2021
Declarations5 total
  • ▲
    StyrelseledamotExecutives
    394,000 SEK0FI-SE
    100,000 shares@ SEK 3.94100.0% of flowOptionISIN SE0005676103FI:csv-8847886cfc2e52da0141
    Canonical exit: 8 Dec 2021 (T+90)
  • ▲
    StyrelseledamotExecutives
    97,536 SEK9FI-SE
    4,064 shares@ SEK 24.0019.0% of flowAktieISIN SE0013110046FI:csv-f942bb90a96b4ded75f7
    Canonical exit: 3 Jun 2021 (T+90)
  • ▲
    StyrelseledamotExecutives
    39,120 SEK8FI-SE
    1,630 shares@ SEK 24.007.6% of flowAktieISIN SE0013110046FI:csv-75be6c346e248719d644
    Canonical exit: 2 Jun 2021 (T+90)
  • ▲
    StyrelseledamotExecutives
    95,520 SEK9FI-SE
    3,980 shares@ SEK 24.0018.7% of flowAktieISIN SE0013110046FI:csv-a54d1b3def7ebe83f360
    Canonical exit: 1 Jun 2021 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutives
    294,500 SEK15FI-SE
    9,500 shares@ SEK 31.00100.0% of flowAktieISIN SE0013110046FI:csv-d2c52f887eb3bc242c39
    Canonical exit: 25 Dec 2019 (T+90)

5 of 5 declarations

About Ortoma A

Ortoma A is a company listed on the XSTO exchange, specializing in the development of technological solutions for the medical sector. It primarily focuses on innovation in the field of orthopedic surgery.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations